The outlook for full year 2025 remains unchanged at flat to 1% currency-neutral revenue growth, consistent with the Q2 update. Margins guidance is also unchanged. Q3 reported a slight revenue and ...
Upslope Capital Management, an investment management company, released its third-quarter investor letter. A copy of the ...
Bio-Rad Laboratories Inc. reported its earnings for the second quarter of 2025, revealing a modest increase in net sales and a stable financial performance. Despite a challenging market environment, ...
Detroit, Michigan--(Newsfile Corp. - October 13, 2025) - Artificial Intelligence Technology Solutions, Inc. (OTCID: AITX) (the "Company"), a global leader in AI-driven security and productivity ...
Andhra Pradesh Chief Minister N. Chandrababu Naidu inaugurated the socio-economic initiatives of the Chinta Sasidhar Foundation, the philanthropic arm of the Vishwa Samudra Group, on the Nandha ...
PHILADELPHIA, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell ...
NEW YORK – Bio-Rad Laboratories has obtained the CE mark for next-generation versions of its Specialty Immunoassay Plus quality control reagents, the firm said Wednesday. The SPIA Plus quality ...
The partnership is said to help radiologists manage their growing workload without compromising the quality of patient care. Credit: Frame Stock Footage/Shutterstock.com. The Radiological Society of ...
-Clinical data to date supports a potentially transformational approach to treating autoimmune diseases with an off-the-shelf, one-time therapy- -As of the August 31, 2025 data cut-off date, all seven ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback